Download our latest application note showcasing how our cutting-edge NGS-based solution enables high-quality tumor profiling at an accessible cost. Designed for pan-cancer applications, our DNA kit ensures accurate detection of key biomarkers such as TMB and MSI, with broad gene coverage and seamless compatibility with MGI’s DNBSEQ™ sequencing platforms.
From sample to clinical insight, this application note demonstrates the performance of our technology—combining optimized library preparation, powerful sequencing, and rapid analysis with OncoKDM®, our intuitive BioIT platform for fast and actionable reporting.
This application note is the result of a collaboration between OncoDNA, MGI, and Sistemas Genómicos, who facilitated the sample analysis.
Download the application note now and discover how we help transform genomic data into clinical decisions.
